• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The solution structure of the active domain of CAP18--a lipopolysaccharide binding protein from rabbit leukocytes.

作者信息

Chen C, Brock R, Luh F, Chou P J, Larrick J W, Huang R F, Huang T H

机构信息

Division of Structural Biology, Academia Sinica, Nankang, Taipei, Taiwan, ROC.

出版信息

FEBS Lett. 1995 Aug 14;370(1-2):46-52. doi: 10.1016/0014-5793(95)00792-8.

DOI:10.1016/0014-5793(95)00792-8
PMID:7649303
Abstract

We have employed the circular dichroism (CD) technique to characterize the solution structure of CAP18(106-137), a lipopolysaccharide (LPS) binding, antimicrobial protein, and its interaction with lipid A. Our results revealed that CAP18(106-137) may exist in at least three lipid A concentration-dependent, primarily helix conformations. The 'model' structure of CAP18(106-137) in 30% (v/v) TFE, determined by nuclear magnetic resonance (NMR) technique, was found to be a complete and very rigid helix. In this conformation, the cationic and hydrophobic groups of CAP18(106-137) are separated into patches and stripes in such a way that it can favorably interact with lipid A through either coulombic interaction with the diphosphoryl groups or hydrophobic interaction with the fatty acyl chains.

摘要

相似文献

1
The solution structure of the active domain of CAP18--a lipopolysaccharide binding protein from rabbit leukocytes.
FEBS Lett. 1995 Aug 14;370(1-2):46-52. doi: 10.1016/0014-5793(95)00792-8.
2
Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes.
FEBS Lett. 1994 Feb 14;339(1-2):108-12. doi: 10.1016/0014-5793(94)80395-1.
3
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein.人源CAP18:一种新型抗微生物脂多糖结合蛋白。
Infect Immun. 1995 Apr;63(4):1291-7. doi: 10.1128/iai.63.4.1291-1297.1995.
4
Structure and functions of endotoxin-binding peptides derived from CAP18.源自CAP18的内毒素结合肽的结构与功能
Prog Clin Biol Res. 1995;392:317-26.
5
Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity.具有脂多糖抑制活性的兔阳离子蛋白(CAP18)的特性研究。
Infect Immun. 1994 Apr;62(4):1421-6. doi: 10.1128/iai.62.4.1421-1426.1994.
6
Antimicrobial activity of rabbit CAP18-derived peptides.兔源CAP18衍生肽的抗菌活性。
Antimicrob Agents Chemother. 1993 Dec;37(12):2534-9. doi: 10.1128/AAC.37.12.2534.
7
Design and Synthesis of Lipopolysaccharide-Binding Antimicrobial Peptides Based on Truncated Rabbit and Human CAP18 Peptides and Evaluation of Their Action Mechanism.基于截断兔和人 CAP18 肽的脂多糖结合型抗菌肽的设计与合成及其作用机制评价。
Probiotics Antimicrob Proteins. 2020 Dec;12(4):1582-1593. doi: 10.1007/s12602-020-09648-5.
8
Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.抗菌肽CAP18和CAP11的cathelicidin家族通过阻断脂多糖与CD14(+)细胞的结合来抑制肿瘤坏死因子-α的表达。
J Immunol. 2001 Sep 15;167(6):3329-38. doi: 10.4049/jimmunol.167.6.3329.
9
Anti-microbial activity of human CAP18 peptides.人CAP18肽的抗菌活性。
Immunotechnology. 1995 May;1(1):65-72. doi: 10.1016/1380-2933(95)00006-2.
10
Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide.变形杆菌属脂多糖的生物学活性及其与多粘菌素B和一种18 kDa阳离子抗菌蛋白(CAP18)衍生肽的相互作用。
J Med Microbiol. 2000 Feb;49(2):127-138. doi: 10.1099/0022-1317-49-2-127.

引用本文的文献

1
In Vitro and In Vivo Characterization of Novel Cathelicidin-Based Peptides with Antimicrobial Activity Against .对新型基于cathelicidin的肽进行体外和体内表征,这些肽对……具有抗菌活性
Antibiotics (Basel). 2025 Aug 19;14(8):838. doi: 10.3390/antibiotics14080838.
2
Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation.Cathelicidins:皮肤治疗与临床转化中的机遇与挑战
Antibiotics (Basel). 2024 Dec 24;14(1):1. doi: 10.3390/antibiotics14010001.
3
LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases.
LL-37:结构、抗菌活性及其对淀粉样相关疾病的影响。
Biomolecules. 2024 Mar 8;14(3):320. doi: 10.3390/biom14030320.
4
The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics.抗菌肽人源 cathelicidin LL-37 的结构在模拟膜存在的情况下表现出聚合和通道形成。
Sci Rep. 2020 Oct 15;10(1):17356. doi: 10.1038/s41598-020-74401-5.
5
Nanomaterials for Biosensing Lipopolysaccharide.用于生物传感脂多糖的纳米材料。
Biosensors (Basel). 2019 Dec 21;10(1):2. doi: 10.3390/bios10010002.
6
Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health.抗菌肽(LL-37)在口腔健康中的意义和诊断作用。
Biomolecules. 2017 Dec 5;7(4):80. doi: 10.3390/biom7040080.
7
The Antimicrobial and Antiviral Applications of Cell-Penetrating Peptides.细胞穿透肽的抗菌和抗病毒应用
Methods Mol Biol. 2015;1324:223-45. doi: 10.1007/978-1-4939-2806-4_15.
8
Fluorescence-based force/tension sensors: a novel tool to visualize mechanical forces in structural proteins in live cells.基于荧光的力/张力传感器:一种在活细胞中可视化结构蛋白机械力的新型工具。
Antioxid Redox Signal. 2014 Feb 20;20(6):986-99. doi: 10.1089/ars.2013.5708. Epub 2014 Jan 15.
9
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.评估 LL-37 在体外和体内中和 LPS 的能力。
PLoS One. 2011;6(10):e26525. doi: 10.1371/journal.pone.0026525. Epub 2011 Oct 18.
10
Genetically encoded force sensors for measuring mechanical forces in proteins.用于测量蛋白质中机械力的基因编码力传感器。
Commun Integr Biol. 2011 Jul;4(4):385-90. doi: 10.4161/cib.4.4.15505. Epub 2011 Jul 1.